Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial.

MLA

Kiyota, Naomi, et al. “Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 40, no. 18, June 2022, pp. 1980–90. EBSCOhost, https://doi.org/10.1200/JCO.21.01293.

APA

Kiyota, N., Tahara, M., Mizusawa, J., Kodaira, T., Fujii, H., Yamazaki, T., Mitani, H., Iwae, S., Fujimoto, Y., Onozawa, Y., Hanai, N., Ogawa, T., Hara, H., Monden, N., Shimura, E., Minami, S., Fujii, T., Tanaka, K., Homma, A., … Hayashi, R. (2022). Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 40(18), 1980–1990. https://doi.org/10.1200/JCO.21.01293

Chicago

Kiyota, Naomi, Makoto Tahara, Junki Mizusawa, Takeshi Kodaira, Hirofumi Fujii, Tomoko Yamazaki, Hiroki Mitani, et al. 2022. “Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 40 (18): 1980–90. doi:10.1200/JCO.21.01293.